Key Pharmacy and Compounding Center recalls HYDROXO-B12 PBF MDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, packaged in a 5 mL and 30 mL Glass/ Multiple Dose vials, P
Recalled May 24, 2017 · FDA recall D-0727-2017 · Key Pharmacy and Compounding Center
Hazard
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility. · FDA Class II
Units
27 vials total (25/5 mL vials and 2/30mL vials)
Sold at
Distributed nationwide in U.S.A., Australia and Canada.
Description
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Product
HYDROXO-B12 PBF MDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, packaged in a 5 mL and 30 mL Glass/ Multiple Dose vials, Prepared by Key Compounding Pharmacy
Manufacturer(s)
Key Pharmacy and Compounding Center
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →